Health Condition 1: C719- Malignant neoplasm of brain, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients scheduled to undergo elective craniotomy for supratentorial tumours; ASA 1&2 patients; age 18-65 years of age
Exclusion criteria
Exclusion criteria: Pregnant/nursing women, BMI >35kg/m2; patients with difficult airway, H/O CHF, liver & kidney diseases, COPD, patients with poor GCS & severely raised ICP, Patient refusal, patients requiring >24hours postoperative mechanical ventilation and unable to communicate postoperatively
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare analgesic efficacy of diclofenacsodium sodium and paracetamol within first 48hours after supratentorial craniotomyTimepoint: To compare analgesic efficacy of diclofenacsodium sodium and paracetamol within first 48hours after supratentorial craniotomy | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect of paracetamol and diclofenacsodium on 1) need for rescue analgesia; 2) coagulation profile and platelet function,3) incidence of hem atoms formation/expansion, 4) incidence of PONV, 5)duration of postoperative hospital stay, 6) effect on LFT&RFTTimepoint: Assesed at 12hours 24 hours and at 48hours postoperatively | — |
Countries
India
Contacts
Post graduate institute of medical education and research